[Malpractice in Urology: lessons of clinical and legal safety.]
DISCUSSION: Urology has a medium risk of claims, with a moderate rate of medical professional liability and amount of compensation. There are specific actions that would lead to clinical safety improvements, particularly in testicular pathologies, vasectomy and lithiasis. Finally, more attention should be paid to proper patient information. PMID: 29889035 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Evolution of radical prostatectomy in the Autonomous Community of Madrid.]
Authors: Gómez Rivas J, Cabañas J, Eguibar A, Díez Sebastián J, Rodríguez de Bethencourt F, Aguilera A, Martínez-Piñeiro L Abstract OBJECTIVES: To analyze the implantation of laparoscopic radical prostatectomy (LRP) in the Public Health System in the Autonomous Community of Madrid (CAM) and to investigate the different results between laparoscopic and open radical prostatectomy. METHODS: We performed a retrospective analysis over a database containing data from 25 hospitals in CAM. We chose 8225 patients treated by radical prostatectomy (open or laparoscopic). Da...
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Kidney cancer stage pT3a: Fat invasion versus renal vein invasion.]
CONCLUSIONS: Tumor fat invasion has a lower impact on the CSM of kidney cancer than vascular invasion. PMID: 29889037 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Impact of tumor diameter on prognosis in patients with renal cancer stage pT3a.]
CONCLUSIONS: Although perirenal fat invasion and renal vein invasion (pT3a stage) are accepted as prognostic factors, to differentiate this category by tumor size could improve its predictive quality. The tumor diameter (7cm) should be applied to pT3a tumors in order to improve the accuracy of TNM system. PMID: 29889038 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Usefulness of cold ureteral biopsy during radical cystectomy as a predictor of recurrence risk: Review of our series.]
CONCLUSIONS: In our study, the presence of positive ureteral margins was not associated with an increased risk of recurrence in the anastomosis or UUT. Although it remains a topic for debate, a strategy to follow may be to adapt ureteral cold biopsies to individual risk, thus perform it in patients with bladder CIS. PMID: 29889039 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Endoscopically treated vesicoureteral reflux: Evolution of the recurrences.]
CONCLUSIONS: Most patients with VUR recurrence were asymptomatic, with no alterations in US or DMSA scan. Both endoscopic treatment or surveillance might be appropriate in this setting. These data lead us to reckon that the systematic search for VUR relapse in the asymptomatic patient might not be necessary. Similarly, ultrasound or DMSA monitoring should be aimed to the assessment of established reflux nephropathy, regardless of the possibility of recurrence. PMID: 29889040 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Maintenance of the efficacy of the oxybutynin patch for the treatment of overactive bladder syndrome despite the change in the area of application: study of four cases.]
Authors: Merino Salas S Abstract The transdermal route for administration of anticholinergic drugs can provide efficacy with less systemic adverse effects. The transdermal oxybutynin patch (OXYTDS) offers advantages over oral administration for patients treated for Overactive bladder (OAB) syndrome. The limited evidence on the OXY-TDS patch application areas of the skin, makes difficult counseling patients who require a change to skin zones other than those recommended by the manufacturer. The preliminary experience of four patients included in this case report suggests that changing the application area for the OX...
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Is retrograde intrarenal surgery replacing percutaneous nephrolithotomy as surgical treatment of stone disease: Our clinical experience.
In this study, we aimed to present the distribution of operation numbers for both percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) in terms of age and stone size in order to reveal the changes over the years. METHOD: Between January 2010 and March 2016, 1814 patients were operated for the treatment of renal stones. Patients were directed to the two different operations according to the surgeons' choices: RIRS or PCNL. Prospectively collected data was retrospectively reviewed. RESULTS: In the years 2010, 2011, 2012, 2013, 2014, 2015, and 2016, the number of RIRS applied for the treatment ...
Source: Archivos Espanoles de Urologia - June 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Something is changing in the diagnosis and treatment of non-muscle invasive bladder cancers (NMIBC).
Authors: Sousa Escandón A PMID: 29745920 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Future advances in the endovesical treatment of NMIBC.]
Authors: Unda-Urzaiz M PMID: 29745921 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[BCG and bladder cancer: Past, present and future.]
Authors: Sánchez González Á, Rodríguez Faba O, Mosquera L, Sabiote L, Breda A, Palou Redorta J Abstract BCG has been used in the treatment of NMIBC for more than 40 years. Nevertheless, its exact working mechanisms have not been completely discovered. Clinical and basic research done over all these years has generated much information but it could be summarized in a few simple statements. It has been demonstrated the best route of administration is intravesical, BCG is superior than intracavitary chemotherapy to prevent recurrence but its adverse events are worse. Recently, it has been d...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

BCG therapy in NMIBC: How much and for how long?.
Authors: Ashton A, Murthy Kusuma VR, Crew J, Mostafid AH Abstract Since its introduction in 1976 Bacille Calmette- Guerin (BCG) has become the standard of care in high risk non-muscle-invasive bladder cancer (NMIBC). Despite more than 40 years of experience, we do not know the most optimal BCG dose to maximize effectiveness whilst minimizing side effects. There is universal agreement that an initial induction course of BCG should consist of 6 weekly instillations if tolerated. However, with regards to the actual dose, data on the comparative effectiveness of one third dose versus full dose BCG is inconclusive. Simi...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[BCG therapy in NMIBC: How much and for how long?.]
This article is a review of the therapeutic options of tumor recurrence after failure of BCG treatment. PMID: 29745924 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Mechanism of action of intravesical BCG. Biological bases and clinical applicability.]
We describe the role of interactions basally established between urothelial tumor cells and cellular and molecular elements of the immune system of the patients with ulterior antitumor effector capacity. After intravesical BCG therapy and its interaction, we describe the various phases of its mechanism of action, namely fixation, internalization and triggering of the lytic cytotoxic antitumor response, and its integration in the current intravesical treatment regimens The implication of all these mechanisms in the varied capacity of clinical response observed in patients, reviewing the current status of knowledge of BCG me...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Immediate post TURBT MMC instillation.]
The objective of this chapter is to perform a comprehensive updated review on the use of MMC in the context of single early instillation at the time of TURBT, the available clinical evidence, most relevant recommendations in the international clinical guidelines, its complications and potential maneuvers for the optimization of its use. PMID: 29745926 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[New endovesical chemotherapy drugs and application vehicles.]
Authors: Rios González E, Martínez-Piñeiro L Abstract Urothelial bladder cancer is a very prevalent disease. At the time of diagnosis 70-80% of the cases present as non muscle invasive tumors. These tumors present a high recurrence and progression rates despite intravesical treatment with Bacille Calmette-Guerin and mitomycin C. Moreover, bladder conditions such as its wall impermeability and the fact that intravesical drugs are constantly being diluted by urine and eliminated do not favor the efficacy of intravesical treatment. This review analyzes new intravesical drugs such as gemcitabine or...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway.
Authors: Barclay J, Creswell J, León J Abstract Long-term survival for patients with advanced bladder cancer is precarious, with a 5-year survival of just 5% in metastatic cases. Normally, the binding of PD-L1 to PD-1 alters the immune activity by modulating it to inhibit autoimmune diseases or chronic inflammation. However, some cancers use this route to block the immune response of the patient and continue growing. The new immunotherapy against bladder cancer aims to block the ability of tumor cells to resist patient' immune response by acting on the checkpoints of immune cells. These drugs are able to blo...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.]
Authors: Coenen JJMJH, van Valenberg FJP, Arends TJH, Witjes JA Abstract In an effort to decrease recurrence and progression rates in non-muscle-invasive bladder cancer (NMIBC), transurethral resection of a bladder tumor is followed by intravesical instillations using Mitomycin-C (MMC) and Bacillus Calmette-Guérin (BCG). In spite of these adjuvant treatment modalities, recurrence and progression rates remain high. Because of these limitations of current standard therapy and the shortage of BCG, there is a search for alternative forms of treatment in NMIBC. Intravesical MMC combined with hyperthermia, especia...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[EMDA with MMC. Critical review.]
Authors: Solsona E Abstract Two Phase II studies, three Phase III and one observational study seem to justify that EMDA-MMC is a real alternative in the treatment of patients with NMIBC, especially the high risk group. The phase III studies compare EMDA-MMC with passive diffusion MMC and BCG in patients with bladder TIS. They showed EMDA MMC superiority compared to passive diffusion MMC and similar to BCG in achieving complete response at 3 and 6 months. In another randomized study on pT1 NMIBC patients, comparing a sequential scheme of BCG plus EMDA-MMC and BCG, the sequential regimen was significantly superior th...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Mitomycin C HIVEC. Update and results in high risk patients.]
Authors: Guerrero-Ramos F, Castellano-Gauna D, García-Rojo E, Duarte-Ojeda JM, de la Rosa-Kehrmann F, Villacampa-Aubá F Abstract Adjuvant endovesical treatment is a research field in constant exploration with the aim to minimize the risk of recurrence and progression of non muscle invasive bladder tumors. Over the last years, the administration of chemotherapy in a chemo hyperthermia regimen has been added to the existing regimens. There are various systems for its administration, but this article focus on HIVEC (Hyperthermic IntraVEsical Chemotherapy) and its current status. In this review article we...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
CONCLUSIONS: QHT has proven to be a safe alternative for the treatment of intermediate and high risk NMIBC, with AE mainly grade 1-2. The AEs reported have little variation with respect to the dose of MMC used, presenting different "profiles" related to the device used for its administration. The treatments with QHTMMC are well tolerated, without adding significantly more AE than the instillations of MMC alone and presenting a better toxicity profile than those reflected in the literature with respect to the treatment with BCG. PMID: 29745932 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Neoadjuvant chemohyperthermia: Our experience after 10 years.
We present our experience with this treatment. METHODS: We performed a case control study in a group of 104 patients with middle-high risk NMIBC. 43 of them received neoadjuvant recirculated intravesical QHT and 61 passively administered standard adjuvant MMC. Patient follow up was 43 months (3 - 108) evaluating their clinical efficacy and adverse effects in both groups. RESULTS: After neoadjuvant QHT, 27 patients showed CR (63%), 13 PR (30.2%) and 3 NR (6.9%). 5 year recurrence rate after QHT passive MMC were 16.2% and 26.2% respectively. No patient in the QHT group presented tumor progression compared to 5% progr...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX ®.
Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX®. Arch Esp Urol. 2018 May;71(4):447-452 Authors: Aminsharifi A, Brousell SC, Chang A, León J, Inman BA Abstract Disease recurrence and progression remain as significant challenges for the management of non-muscle invasive bladder cancer (NMIBC). In recent years, novel drugs and delivery systems have been investigated as strategies to reduce recurrence, progression and mortality. In this review, we focus on the role of intravesical hyperthermic chemotherapy and discuss a novel approach inv...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Sequential treatment with Mitomycin C and BCG in non muscle invasive bladder cancer.]
Authors: Chantada-Abal V, Chantada-Tirado C, Lamas-Díaz L, Caramés-Masana F, Villegas-Piguave AD, Villar-Vázquez N Abstract Bacilus Calmette-Guerin (BCG) administered intravesical is an effective therapy in non muscle invasive bladder cancer (NMIBC), but it presents limitations regarding recurrence and toxicity. For years, many case series have been published where sequential therapy with BCG and Mitomycin C (MMC) was tried. In this article, we perform a review of the data supplied by these articles with the aim to determine the safety and efficacy of combination, and what is the group of patie...
Source: Archivos Espanoles de Urologia - May 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[New conceptual framework in advanced prostate cancer.]
Authors: Miñana López B PMID: 29633942 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Locally advanced prostate cancer. Definition, diagnosis and treatment.]
CONCLUSIONS: Prostate cancer local staging is currently based on multiparametric magnetic resonance imaging (mpMRI). Local radical treatment with surgery or radiotherapy, with probable addition of systemic treatment, offers promising results for disease control and quality of life improvement. PMID: 29633943 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Oligometastatic prostate cancer. concept and implications.]
Authors: Carrasco Valiente J, Ruiz García JM, Requena Tapia MJ Abstract Oligometastatic prostate cancer has been proposed as an intermediate stage between localized and extensively disseminated disease. Oligometastatic disease is being diagnosed more frequently due to the advances in imaging tests. Nevertheless, there is no consensus definition yet of oligometastatic prostate cancer. The importance of this entity is that several studies have pointed out that local and metastasis directed treatment may improve survival in selected patients. However, we need the results of well controlled prospective randomize...
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Current status of androgen deprivation therapy in hormone-sensitive prostate cancer.]
CONCLUSIONS: Close monitoring of PSA and testosterone levels is necessary in patients with metastatic prostate cancer during hormone deprivation treatment. Combination of both values allows to predict treatment response and early identification of tumor progression, and to put forward subsequent therapeutic strategies improving survival in this group of patients. PMID: 29633945 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Preventive management of bone disease in advanced prostate cancer.]
CONCLUSIONS: Comprehensive management of the patient with advanced prostate cancer should include the study and treatment of osteoporosis and bone metastases. Currently, very effective therapies are available for both entities. PMID: 29633946 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Maximal androgen deprivation with abiraterone acetate in hormone sensitive prostate cancer.]
Authors: Rodríguez Antolín A, Romero Otero J, Duarte Ojeda J, García González L, Sopeña Sutil R, González Padilla D, García Rojo E, Justo Quintas J, Miñana López B Abstract OBJECTIVES: The treatment of metastatic prostate cancer has remained unchanged for more than 70 years, based on androgen deprivation therapy (ADT). In 2015, following the CHAARTED and STAMPEDE trials, it was established that the addition of 6 cycles of docetaxel to ADT was associated with significantly increased survival. In June 2017, the LATITUDE trial and the G arm of the STAMPEDE...
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer.]
CONCLUSIONS: The addition of docetaxel to treatment with HB should be considered in patients with MHSPC, especially in those with high tumor volume. However, the toxicity and recent results of trials performed with abiraterone in MHSPC should also be taken in consideration. PMID: 29633948 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[The role of corticoids in the management of advanced prostate cancer.]
Authors: González-Del-Alba Baamonde A, Sevillano Fernández E Abstract Prostate cancer is the most frequent malignant tumor in males in developed countries and represents the second cause of cancer death. Over the last years, the number of treatments available for patients with advanced prostate cancer has improved significantly, achieving better disease control and notably better overall survival (1). Corticosteroids have been extensively used in the treatment of castration resistant prostate cancer due to their palliative benefits on symptoms secondary to their potent anti-inflammatory activity and t...
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Surgical treatment of local disease in metastatic prostate cancer.]
CONCLUSIONS: In absence of prospective randomized data, radical prostatectomy seems to be useful for local treatment of the primary tumor in a selected group of patients with oligometastatic prostate cancer. PMID: 29633950 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Radiotherapy for local disease in metastatic prostate cancer.]
CONCLUSIONS: Primary tumor radiotherapy in omPca positively influences local control and prevention of local symptoms progression. The level of evidence to recommend prostatic radiotherapy as a therapeutic variable with impact on survival on omPca is limited (Level 2B-3 Category). Research lines in omPca deserve the inclusion of a multimodal systemic treatment including ADT, ablative radiotherapy for the tumor and consolidation radiotherapy in metastatic distant lesions. PMID: 29633951 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Advanced prostate cancer and quality of life.]
CONCLUSIONS: To propose the most adequate treatment in patient`s interest, we need results focused on patients that combine not only quantity or overall survival but also quality of life. Parameters such as QALY should be included in clinical trials as evaluation objectives in order to favor decision taking. PMID: 29633952 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Multidisciplinary teams in the treatment of prostate cancer.]
Authors: Climent MÁ, Rubio-Briones J Abstract In the last decade, prostate cancer management has dramatically evolved to such a complexity that different medical specialties have to participate for its optimization, even making necessary in many cases super specialization in every discipline for such aim. All Guidelines and every Scientific Association do recommend multidisciplinary teams for its management as a rule, but translation from multidisciplinary committees to daily assistance is heterogeneous and faces, many times, particular interests and conflicts between different specialties implying that obje...
Source: Archivos Espanoles de Urologia - April 13, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Rectovesical fistula after laparoscopic radical prostatectomy secondary to the use of hem-o-lock clips.]
Authors: Martínez RH, González Satue C, Alves Oliveira M, Ibarz Servio L PMID: 29521262 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with Proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections.]
CONCLUSION: Manosar® (oral once a day) is more effective than single dose PAC (240 mg daily orally) to prevent recurrent UTI in women. PMID: 29521263 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Application of ERAS (Enhanced Recovery After Surgery) and laparoscopic surgery in the management of patients with bladder cancer.
CONCLUSIONS: Introduction of ERAS protocol in radical cystectomy decreases the length of hospital stay, permanence in critical care units, and the need for fluidtherapy and blood product transfusion. However, more and larger studies are needed to prove the efficacy of ERAS for patients undergoing radical cystectomy. PMID: 29521264 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Efficacy of lycopene intake in primary prevention of prostate cancer: a systematic review of the literature and meta-analysis.]
CONCLUSIONS: Although our study found that there is a statistically significant inverse association between lycopene intake and PCa, the magnitude of this association is weak and comes solely from observational studies, which do not allow recommending its use as a standard of practice. High-quality randomized clinical trials are required to clarify current evidence. PMID: 29521265 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Laparoscopic partial nephrectomy using the Simon clamp: our experience in 18 cases.
CONCLUSIONS: Laparoscopic partial nephrectomy using the Simon clamp for vascular control is a feasible technique for selected cases with polar exophytic tumors. Immediate postoperative glomerular filtration rate showed no significant changes and oncological control in our experience was satisfactory. PMID: 29521266 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Small cell bladder carcinoma in age extremes: Report of two cases.]
CONCLUSIONS: Our cases have been reviewed with the literature to discuss the evolution and differential diagnosis of small cell carcinoma of the urinary bladder. This is a rare tumor with very aggressive behavior and its diagnosis lies in its morphology, and immunohistochemical profile. PMID: 29521267 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Pseudomyxoma peritonei: A case report and review of the literature.
CONCLUSIONS: PMP is a local-regional disease within the abdomen, characterized by a mucinous tumor (mucocele) that produces a progressive amount of mucinous ascites, which eventually blows-out, and tumor cells are spread through the peritoneal cavity. Treatment options differ significantly, depending the stage of the disease. PMID: 29521268 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

The effect of darbepoetin alfa on renal fibrosis in rats with acute unilateral ureteral obstruction.
Authors: Yuksel OH, Yildirim C, Urkmez A, Ozbay N, Uruc F, Sahin A, Akan S, Verit A Abstract OBJECTIVES: The most important treatment strategy for obstructive nephropathy is to protect renal tissue from the deleterious effects of fibrosis. Therefore, we sought to investigate the renoprotective effects of darbepoetin alfa on unilateral ureteral obstructions. METHODS: We used 12 female and 12 male 3-monthold Wistar rats weighing between 250 and 350 g. The rats were divided equally into sham, darbepoetin and control groups. With the exception of the sham group, left unilateral obstructions were applied to all of t...
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Supernumerary lump pelvic kidney: The first case of the literature.
Authors: Kaya E, Zor M, Bozlar U, Uguz S, Ebiloglu T, Bedir S PMID: 29521270 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Bladder foreign body.
Authors: Fabià Mayans A, Segarra Tomás J, Ascaso Til H, Serra Deola A, Centeno Álvarez C, Ruiz Plazas X, Prados Saavedra M, Vila Barja J, Santillana Altimira JM PMID: 29521271 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - March 11, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Surgical and academic education in Urology.]
Authors: Gómez Rivas J PMID: 29336325 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - January 18, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

[Current status of Urological Education in Spain.]
CONCLUSION: The current training program is upgradeable. New studies and efforts should aim to standardize the acquisition of surgical and non-surgical skills, guarantee access to surgical training courses, establish a minimum of required interventions per year and at the end of residency, foster academic training, participation in research of residents and achieve an objective assessment of the specialty. PMID: 29336326 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - January 18, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Current status of urological training in Europe.
We describe a brief description of the most important EAU and ESU opportunities. PMID: 29336327 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - January 18, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Needs, realities and expectations for urology training: Questionaire-based study.
CONCLUSION: Urological education must be standardized and must cover the educational needs of urology residents. PMID: 29336328 [PubMed - in process] (Source: Archivos Espanoles de Urologia)
Source: Archivos Espanoles de Urologia - January 18, 2018 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research